| 000 | 01663 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517113948.0 | ||
| 264 | 0 | _c20171219 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1756-9966 | ||
| 024 | 7 |
_a10.1186/s13046-016-0411-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRovithi, Maria | |
| 245 | 0 | 0 |
_aAlternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth. _h[electronic resource] |
| 260 |
_bJournal of experimental & clinical cancer research : CR _c09 2016 |
||
| 300 |
_a138 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aAutophagy |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aChick Embryo |
| 650 | 0 | 4 |
_aChorioallantoic Membrane _xdrug effects |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHT29 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xadministration & dosage |
| 650 | 0 | 4 | _aPulse Therapy, Drug |
| 650 | 0 | 4 |
_aPyrroles _xadministration & dosage |
| 650 | 0 | 4 | _aSunitinib |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _ade Haas, Richard R | |
| 700 | 1 | _aHoneywell, Richard J | |
| 700 | 1 | _aPoel, Dennis | |
| 700 | 1 | _aPeters, Godefridus J | |
| 700 | 1 | _aGriffioen, Arjan W | |
| 700 | 1 | _aVerheul, Henk M W | |
| 773 | 0 |
_tJournal of experimental & clinical cancer research : CR _gvol. 35 _gno. 1 _gp. 138 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13046-016-0411-2 _zAvailable from publisher's website |
| 999 |
_c26397713 _d26397713 |
||